HIGHLIGHTS
- who: Osteoarthritis and collaborators from the College, And Research Centre, Pune, Business Development Hospitals, Hospitals Ltd have published the article: Review began 10/10/2022 Review ended 10/26/2022 Published 11/03/2022 u00a9 Copyright, in the Journal: (JOURNAL) of November/03,/2022
- what: This study was conducted to evaluate the effectiveness and safety of intra-articular injection of Wockhardt`s Ossinextu2122 an autologous growth factor concentrate (AGFC) versus HA in KOA. A total of 24 patients reported 37 adverse events (AEs) during the study most common being pain pyrexia and swelling but none . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.